Nobutoshi Ito

Dr. Nobutoshi Ito

orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
19 August 2008 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MNMakoto Nakabayashi
Makoto Nakabayashi
SYSachiko Yamada
Sachiko Yamada
NYNobuko Yoshimoto
Nobuko Yoshimoto
TTTakashi Tanaka
Takashi Tanaka
MIMiharu Igarashi
Miharu Igarashi
MSMasato Shimizu
Masato Shimizu

4 February 2009 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
YIYuka Inaba
Yuka Inaba
NYNobuko Yoshimoto
Nobuko Yoshimoto
YSYuta Sakamaki
Yuta Sakamaki
MNMakoto Nakabayashi
Makoto Nakabayashi
TITeikichi Ikura
Teikichi Ikura
KYKeiko Yamamoto
Keiko Yamamoto

1 August 2013 in Journal of Lipid Research
Verified
Journal Article
Open access
PDF file
HMHiroyuki Masuno
Hiroyuki Masuno
TITeikichi Ikura
Teikichi Ikura
DMDaisuke Morizono
Daisuke Morizono
IOIsamu Orita
Isamu Orita
SYSachiko Yamada
Sachiko Yamada
NINobutoshi Ito
Nobutoshi Ito
Hiroyuki Masuno, Teikichi Ikura, Daisuke Morizono, Isamu Orita, Sachiko Yamada, Masato Shimizu, Nobutoshi Ito

24 October 2016 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
CAChizuru Akatsu
Chizuru Akatsu
KSKenro Shinagawa
Kenro Shinagawa
NNNobutaka Numoto
Nobutaka Numoto
ZLZhihong Liu
Zhihong Liu
AUAyse Konuskan Ucar
Ayse Konuskan Ucar
TTTakeshi Tsubata
Takeshi Tsubata
Toll-like receptor 7 (TLR7) plays an essential role in development of systemic lupus erythematosus by co-stimulating B cells reactive to the endogenous TLR7 ligand Sm/ribonucleoprotein (RNP), a crucial lupus self-antigen. However, how the TLR7-mediated autoimmune response is regulated is not yet known. In this study, we demonstrate that CD72, an inhibitory B cell co-receptor known to prevent development of lupus, recognizes Sm/RNP at the extracellular C-type lectin-like domain (CTLD) and specifically inhibits B cell response to Sm/RNP. Moreover, the CTLD of CD72c, a lupus-susceptible allele, binds to Sm/RNP less strongly than that of lupus-resistant CD72a. Reduced binding of CD72c is supported by x-ray crystallographic analysis that reveals a considerable alteration in charge at the putative ligand-binding site. Thus, CD72 appears to specifically inhibit B cell response to the endogenous TLR7 ligand Sm/RNP through CTLD-mediated recognition of Sm/RNP, thereby preventing production of anti-Sm/RNP antibody crucial for development of lupus.

1 June 2008 in Protein Science
Verified
Journal Article
Open access
PDF file
YUYoshiaki Urakubo
Yoshiaki Urakubo
TITeikichi Ikura
Teikichi Ikura
NINobutoshi Ito
Nobutoshi Ito
The complex of barnase (bn) and barstar (bs), which has been widely studied as a model for quantitative analysis of protein-protein interactions, is significantly destabilized by a single mutation, namely, bs Asp39 --> Ala, which corresponds to a change of 7.7 kcal x mol(-1) in the free energy of binding. However, there has been no structural information available to explain such a drastic destabilization. In the present study, we determined the structure of the mutant complex at 1.58 A resolution by X-ray crystallography. The complex was similar to the wild-type complex in terms of overall and interface structures; however, the hydrogen bond network mediated by water molecules at the interface was significantly different. Several water molecules filled the cavity created by the mutation and consequently caused rearrangement of the hydrated water molecules at the interface. The water molecules were redistributed into a channel-like structure that penetrated into the complex. Furthermore, molecular dynamics simulations showed that the mutation increased the mobility of water molecules at the interface. Since such a drastic change in hydration was not observed in other mutant complexes of bn and bs, the significant destabilization of the interaction may be due to this channel-like structure of hydrated water molecules.

29 August 2013 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MNMakoto Nakabayashi
Makoto Nakabayashi
YTYoshito Tsukahara
Yoshito Tsukahara
YIYukiko Iwasaki-Miyamoto
Yukiko Iwasaki-Miyamoto
MMMika Mihori-Shimazaki
Mika Mihori-Shimazaki
SYSachiko Yamada
Sachiko Yamada
NINobutoshi Ito
Nobutoshi Ito